Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults

NCT04966871 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: PfSPZ Vaccine
BIOLOGICAL: PfSPZ Challenge (7G8) for CHMI
OTHER: Normal Saline

Sponsor

Sanaria Inc.

Collaborators

[object Object]